Tekla Life Sciences Investors (HQL)

USD 11.44

(2.65%)

Market Cap (In USD)

312.75 Million

Revenue (In USD)

23.52 Million

Net Income (In USD)

22.35 Million

Avg. Volume

137.29 Thousand

Currency
USD
Country
Financial Services
Open
-
Prev. Close
-
Day Range
-
Year Range
12.76-15.9
PE
3.86
EPS
2.96
Beta Value
0.705
ISIN
US87911K1007
CUSIP
87911K100
CIK
884121
Shares
27350500.0
Earnings Annoncement
-

Company Profile

Sector
Financial Services
Industry
Asset Management
CEO
Dr. Daniel R. Omstead M.S, Ph.D.
Employee Count
-
Website
https://www.teklacap.com/hql.html
Ipo Date
1992-05-01
Details
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.